Examining the efficacy of different iron supplements in wome

Not Applicable

Recruiting

• Conditions: iron deficiency; Blood - Anaemia

• Registration Number: ACTRN12623000529640
• Lead Sponsor: Australian Catholic University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2023-05-19
• Last Update Posted: 12 August 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: Female
• Target Recruitment: 80

Inclusion Criteria

Females with serum ferritin concentrations below 50 ug/L.. Must also fit one of the below groups:
1.Female endurance athletes, aged 18-40 years old, must be running ~40 km per week or more; naturally menstruating;
2.Team sport athletes, aged 18-40 years old, must be participating in structured training at least 3 times/ week; naturally menstruating.
3.Active Women, aged 18-40 years old, naturally menstruating; must meet WHO’s criteria for physically active, however not meeting the training threshold or competing in endurance/team sports.
4.Postmenopausal women, aged 40-70 years old, deemed post-menopausal; not using hormonal replacement therapy; must meet WHO’s criteria for physically active, however not meeting the training threshold or competing in endurance/team sports.

Exclusion Criteria

The exclusion criteria for all participants includes use of hormonal contraception, pregnant, chronic diseases (i.e., diabetes, cancer, heart diseases) and/or a recent iron infusion (within 12 weeks). All participants must be willing to abstain from oral iron supplementation for 14 days prior to the first measurement.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Serum ferritin[ 0. 4. 8 and 12 weeks following the supplement commencement. ]

Secondary Outcome Measures

Name	Time	Method
Cumulative symptom score using a 3 points scale (mild, moderate and severe)[ assessed daily for 12 weeks following the supplement commencement]